JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

/ Jones, Amy V. ; Chase, Andrew ; Silver, Richard T. .. — 2009-04

Response of ETV6-FLT3 positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3

/ Walz, Christoph ; Erben, Philipp ; Ritter, Michael .. — 2011-08-25

Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha

/ Jones, Amy V. ; Silver, Richard T. ; Waghorn, Katherine .. — 2006

Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia

/ Huang, Kuan-Po ; Chase, Andrew J. ; Cross, Nicholas C.P. .. — 2008-09

JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia13

/ Kramer, Alwin ; Reiter, Andreas ; Kruth, Jens .. — 2007

Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia

/ Kreil, S. ; Pfirrmann, M. ; Haferlach, C. .. — 2007

The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1

/ Macdonald, D. ; Reiter, A. ; Cross, N.C. — 2002

Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia

/ Reiter, Andreas ; Saussele, Susanne ; Grimwade, David .. — 2003

The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1

/ Walz, C. ; Chase, A. ; Schoch, C. .. — 2005

Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemia

/ Walz, Christopher ; Grimwade, David ; Saussele, Susanne .. — 2010-05